Drug Pricing & Innovation

Japan’s Drug Innovation Incentive Policies: Policy Challenges Undermine Desired Goals (ENG)

The Asia Group (TAG) has released an update to its 2023 white paper “Observations on Drug Pricing and Innovation in Japan” which analyzes the outstanding policy challenge of the “zero co-factor” rule under the cost-based price calculation method, which continues to undermine the Japanese government’s efforts to restore the country’s drug discovery capabilities and create a robust pharmaceutical industry ecosystem.

Japan’s Drug Innovation Incentive Policies: Policy Challenges Undermine Desired Goals (ENG) Read More »

TAG Paper: Observations on Drug Pricing and Innovation in Japan

Full Paper (English): TAG Paper: Observations on Drug Pricing and Innovation in Japan ENG Full Paper (Japanese): TAG Paper: Observations on Drug Pricing and Innovation in Japan JPN Key Findings As the Government of Japan (GOJ) seeks to re-invigorate Japan’s pharmaceutical industry as a sector for innovation and growth, it can make impactful changes to specific pricing

TAG Paper: Observations on Drug Pricing and Innovation in Japan Read More »

The Asia Group Serves as Key Strategic and Sales Advisor to Groundbreaking Collaboration Agreement to Bring MRNA Vaccine Technology to Vietnam

FOR IMMEDIATE RELEASE HANOI, Vietnam; WASHINGTON DC, United States, August 2, 2021 – The Asia Group, LLC (“TAG”), a leading Washington-based strategic advisory firm supporting global businesses and investors across the Indo-Pacific, is proud to announce its efforts as principal strategic and sales advisor to a groundbreaking collaboration and licensed production agreement between Arcturus Therapeutics

The Asia Group Serves as Key Strategic and Sales Advisor to Groundbreaking Collaboration Agreement to Bring MRNA Vaccine Technology to Vietnam Read More »

Scroll to Top

You Are Applying For:

The Asia Group Serves as Key Strategic and Sales Advisor to Groundbreaking Collaboration Agreement to Bring MRNA Vaccine Technology to Vietnam

Apply Now

Submit the details below, and our HR team member will get in touch with you shortly.

The Asia Group is an equal opportunity employer where an applicant’s qualifications are considered without regard to race, color, religion, sex, national origin, age, disability, veteran status, genetic information, sexual orientation, gender identity or expression, or any other basis prohibited by law. The Asia Group continually seeks to diversify its staff, particularly to broaden opportunities for individuals from demographic groups that are historically underrepresented in the strategic advisory profession.

"*" indicates required fields

1Personal Details
2Questionnaire & Application Materials
3Voluntary Self Identification

Personal Details

Name*
Address*